The expression of Ki-67 in HCC tissues of rats with sorafenib sensitive stage was lower than that of rats with drug resistance stage, indicating that sorafenib inhibited the proliferation of HCC cells (Figures 6A, B). This evidence concerns the gene MKI67 and hepatocellular carcinoma.